0000927066-17-000094.txt : 20171212
0000927066-17-000094.hdr.sgml : 20171212
20171212195746
ACCESSION NUMBER: 0000927066-17-000094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171208
FILED AS OF DATE: 20171212
DATE AS OF CHANGE: 20171212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZUMWALT LEANNE M
CENTRAL INDEX KEY: 0001204946
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 171252848
MAIL ADDRESS:
STREET 1: C/O THE ADVISORY BOARD CO WATERGATGE
STREET 2: 600 NEW HAMPSHIRE AVE NW
CITY: WASHINGTON
STATE: DC
ZIP: 20037
FORMER NAME:
FORMER CONFORMED NAME: ZURNWALT LEANNE M
DATE OF NAME CHANGE: 20021109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wf-form4_151312665238950.xml
FORM 4
X0306
4
2017-12-08
0
0000927066
DAVITA INC.
DVA
0001204946
ZUMWALT LEANNE M
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
Grp VP, Purch & Public Affairs
Common Stock
2017-12-08
4
M
0
5400
55.34
A
12423
D
Common Stock
2017-12-08
4
F
0
4451
67.14
D
7972
D
Common Stock
2017-12-08
4
S
0
949
68.1889
D
7023
D
Stock Appreciation Rights
55.34
2017-12-08
4
M
0
5400
0
D
2017-12-18
Common Stock
5400.0
0
D
Represents the weighted average sale price of $68.1889. The range of prices for the sale of these shares was $68.1700 - $68.2100 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Stock Appreciation Rights were granted on 12/18/2012. 50% vested on 4/1/2015 and the remaining 50% vested on 4/1/2016.
/s/ Arturo Sida, Attorney-in-Fact
2017-12-12